Status:
NOT_YET_RECRUITING
A Dyadic e-Health System on Enhancing Healthy Lifestyles of Older Adults With Sarcopenia
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Sarcopenia
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Sarcopenia is defined as a reduction in muscle mass, muscle strength, and physical performance. Without proper management, sarcopenia may result in adverse health outcomes. Continuously maintain healt...
Detailed Description
Sarcopenia is defined as a reduction in appendicular skeletal muscle mass, muscle strength, and physical performance. The prevalence of sarcopenia is high, and it appears in about 25% of local older a...
Eligibility Criteria
Inclusion
- Community-dwelling older people aged \> 60 years;
- Meeting the diagnostic criteria of sarcopenia according to the Asian Sarcopenia Working Group (ASWG):
- Early-stage sarcopenia refers to the fulfillment of one of the following criteria: low handgrip strength \< 28 kg for men and \< 18 kg for women, low muscle quality as reflected by low appendicular skeletal muscle mass (ASM) /height squared \< 7 kg/m2 for men and \<5.7 kg/m2 for women, or low physical performance with a Short Physical Performance Battery (SPPB) score of \< 9;
- Able to communicate, read, and write in Chinese without significant hearing and vision problems to ensure that our instructions are understood;
- Own a smartphone, and able to access the internet at home or elsewhere;
- Reside with family and have at least one daily shared meal (family is defined as an individual who has a significant personal relationship with the participant, such as next of kin, spouse and the individual must be at aged \> 18); and
- Able to identify a family member who has a smartphone and is willing to support the participant to use the e-Health System.
Exclusion
- With any form of disease or condition that might affect food intake and digestion (such as severe heart or lung diseases, diabetes, cancer, or autoimmune diseases);
- Currently suffering from acute gouty arthritis or had a gout attack in the past year;
- Taking medications that may influence eating behaviour, digestion, or metabolism (such as weight loss medication);
- Being addicted to alcohol, which might affect the effort to change dietary behaviour;
- Having impaired mobility, which might affect participation in exercise training, as defined by a modified Functional Ambulatory Classification score of \< 7;
- Having renal impairment, based on the renal function blood test which will be screened by a geriatrician;
- Having depressive symptomatology, defined by a Geriatric Depression Scale score of \> 8;
- Suffering from dementia (i.e., MoCA\<20 or clinical dementia rating ≥1);
- Having any medical implant device such as a pacemaker, because low-level currents will flow through the body when doing the bioelectric impedance analysis (BIA by InBody S10, Korea), which may cause the device to malfunction.
Key Trial Info
Start Date :
May 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT06088511
Start Date
May 6 2024
End Date
January 1 2026
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic Universtiy
Hong Kong, Hong Kong